5 Am Venture Management, LLC Arvinas, Inc. Transaction History

5 Am Venture Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$32.47 - $57.24 $2.6 Million - $4.58 Million	-80,000 Reduced 20.0%	320,000 $10.9 Million
Q2 2021 Aug 16, 2021	SELL	$60.45 - $84.26 $6.05 Million - $8.43 Million	-100,000 Reduced 20.0%	400,000 $30.8 Million
Q4 2020 Feb 16, 2021	SELL	$20.19 - $84.93 $10.1 Million - $42.5 Million	-500,000 Reduced 50.0%	500,000 $42.5 Million
Q1 2020 Apr 29, 2020	SELL	$33.0 - $54.5 $12.5 Million - $20.6 Million	-378,423 Reduced 27.45%	1,000,000 $40.3 Million
Q4 2019 Feb 05, 2020	BUY	$15.39 - $44.38 $21.2 Million - $61.2 Million	1,378,423 New	1,378,423 $56.6 Million

222

68.8M

166K

31.3K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.44B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of 5 Am Venture Management, LLC, based on Form 13F filings with the SEC.

Stay updated on 5 Am Venture Management, LLC with notifications on news.